The Digestive Challenge: Why Oral Peptide Delivery Has Failed for Over a Century
By
odedfalik
Pure flour-power. Hearty enough to carry you through lunch.
Summary
The article explains the fundamental challenge of oral peptide delivery, focusing on how the human digestive system is designed to break down peptides and proteins. It describes the gastrointestinal tract as a 30-foot disassembly line where stomach acid denatures proteins, enzymes like pepsin and trypsin cleave them, and the intestinal mucus layer blocks absorption. The article highlights that for over a century, attempts to deliver therapeutic peptides orally have failed because the digestive system efficiently destroys peptide chains before they can reach the bloodstream, using semaglutide as a specific example of a peptide that faces this challenge.
Key quotes
· 5 pulledYour stomach's entire job is to destroy peptides. It's the whole point of your stomach.
Your GI tract is a 30-foot disassembly line for proteins. Acid denatures them, pepsin cleaves them, trypsin finishes the job.
Anything that looks like a chain of amino acids gets shredded into fragments before it can reach your bloodstream.
This is what's supposed to happen. It's how you digest food.
It's also the reason that for over a century, every attempt to deliver a therapeutic peptide by mouth has run into the same problem.
You might also wanna read
HKUMed develops world-first NanoPowder nasal spray for prehospital ischemic stroke treatment
A research team from HKUMed and InnoHK ABIC has developed the world's first 'NanoPowder nasal spray' for ischemic stroke. This innovation ov

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design
The article discusses recent advancements in AI-driven drug discovery, highlighting two key developments: 1) Analytica 2026, an event focuse
Researchers Reverse Kidney Damage in Mice by Targeting Ceramide-Induced Mitochondrial Damage
Researchers at University of Utah Health discovered that fatty molecules called ceramides trigger acute kidney injury (AKI) by damaging mito
Genomic test trial suggests hormone therapy alone may be sufficient for low-risk breast cancer patients
A groundbreaking genomic test trial suggests that breast cancer patients with low test scores could be treated with hormone therapy alone, a

Study finds bird masturbation is natural behavior, not caused by captivity stress
A study on masturbation among birds, particularly parrots, finds that the behavior is natural and more common in the wild than in captivity.
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
